このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Olfactory Communication in the First Days of Life: From Chemical Mechanisms to Improved Breastfeeding (OD-ALL)

2026年5月26日 更新者:Centre Hospitalier Universitaire Dijon

For a newborn, locating and latching onto the mother's breast is the foundational social interaction. This pivotal moment not only influences the newborn's survival but also determines the mother's physiological (lactation) and psychological (attachment) engagement, as well as the long-term health of both the child and the mother. However, according to the WHO, three out of five newborns are not exclusively breastfed for the recommended 6 months, and several recent studies point to suboptimal rates of breastfeeding initiation in the maternity ward, partly due to difficulties with oral latching, insufficient sucking, or refusal of the breast. This situation compromises the initial intake of colostrum/milk, as well as the establishment of early emotional bonds. A wealth of research data from biology, psychology, and pediatrics shows that neonatal and maternal sensory experiences play a central role in the initiation of breastfeeding. However, our understanding of the sensory and behavioral mechanisms at play remains unclear. While visual and auditory interactions have been extensively documented, other sensory modalities-touch, chemoreception, and kinesthesia-remain largely overlooked, even though their critical role has been documented in other mammals. The inves will focus on the role of olfaction in organizing the adaptive responses of the newborn to the mother's breast and of the mother to her baby.

A wealth of research data from biology, psychology, and pediatrics shows that neonatal and maternal sensory experiences play a central role in the initiation of breastfeeding. However, our understanding of the sensory and behavioral mechanisms involved remains unclear. While visual and auditory interactions have been extensively documented, other sensory modalities-touch, chemoreception, and kinesthesia-have received little attention, even though their critical role has been documented in other mammals. Here, the investigators will focus on the role of olfaction in organizing the adaptive responses of the newborn to the mother's breast and of the mother to her baby.

Research data in humans show that: 1) several mammary secretions (colostrum/milk, areolar secretions) emit odorous compounds, and 2) newborns respond to them in a stereotypical and repeatable manner. These odors, which are specific to the mammary gland, serve to facilitate the very first mother-infant interactions. However, the source of these odorous compounds remains unclear, and their chemical nature is unknown. Without precise chemical identification, it is difficult to fully understand the mechanisms by which odors influence the newborn's behavior toward the mother's breast at the start of breastfeeding. Conversely, the newborn's body odors could also convey information about its emotional or metabolic state and influence maternal motivation and behavior.

Based on research conducted on other mammals, as well as studies focused on our own species, the investigators know that: 1) postpartum mothers are highly receptive to the body odor of their newborns, and 2) newborns emit odor compounds that are appreciated by mothers (even if the infants are not their own) . It cannot therefore be ruled out that human mothers react, even unconsciously, to these infant odors and that these odors could help regulate maternal psychophysiology (particularly that underlying lactation and the related chemocommunication mechanisms).

The OD-ALL project aims to unravel the chemical basis of the olfactory interactions that lead to the establishment of the breastfeeding relationship between each member of the mother-newborn dyad. To this end, the investigators will apply an innovative technology, proton transfer reaction time-of-flight mass spectrometry (PTR-ToF-MS), which has previously been used to monitor volatile organic compounds (VOCs) in the environment. Unlike conventional techniques (such as gas chromatography coupled with mass spectrometry; GC-MS), which allow only sporadic and somewhat disruptive measurements, PTR-ToF-MS records odor emissions in real time, without any disruption to the natural interactions taking place. It is capable of providing a true "chemical video" of the dynamic variations in VOCs of mammary or infant origin (whereas conventional GC-MS provides only a "chemical snapshot"). These fluctuations can thus be correlated with the behaviors and physiological responses of mothers and newborns, which will be recorded concurrently. This approach opens up entirely new avenues for understanding the chemosensory foundations of early human interactions, particularly those that occur during the initiation of breastfeeding. Alongside this fundamental approach, the OD-ALL project aims to raise awareness among healthcare professionals, the general public and health policy makers regarding the role of smell in early interactions between mother and newborn.

調査の概要

研究の種類

観察的

入学 (推定)

364

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 子
  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

サンプリング方法

非確率サンプル

調査対象母集団

Breastfeeding women who have given birth to a single newborn / who may be accompanied by their newborn

説明

Inclusion Criteria:

  • Regarding mothers:

    • Individuals who have provided their consent (studies 1, 2, and 3) as well as that of their child (studies 1 and 3).
    • Adults.
    • Birth of a singleton newborn.
    • Breastfeeding woman (studies 1 and 2).
    • Absence of any infectious risk and any prior morbidity during pregnancy, childbirth, and breastfeeding (determined by medical staff).
  • Regarding newborns:

    • Absence of medical problems during pregnancy, at delivery (full-term birth: 37-42 weeks of amenorrhea, Apgar score > 7 at 1 and 10 minutes; birth weight > 2500 g), or during the neonatal period.

Exclusion Criteria:

  • Regarding mothers:

    • Any mother with an infectious disease (HIV, hepatitis A or B) or under special medical supervision.
    • Mothers taking medication that may alter body odor (e.g., corticosteroids, progestins, antidepressants).
    • Mothers who smoke.
    • Mothers suffering from chronic (confirmed congenital anosmia) or acute impairments of the sense of smell (nasal congestion due to infection or allergy).
    • Mothers subject to legal protective measures (guardianship, conservatorship).
    • Mothers subject to judicial protective measures.
  • Regarding newborns:

    • Any child who experienced medical problems during pregnancy, childbirth, or the neonatal period (Apgar score < 7 at 1, 5, and 10 minutes).
    • Congenital anosmia (if this information is noted in the medical record; for example, in cases of Du Morsier-Kallman syndrome).

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
44 mother-newborn pairs
44 mother-newborn pairs (i.e., n = 44 mothers et n = 44 newborn)
VOC measurement during a breastfeeding session + video and thermographic recording
42 mothers
42 mothers (collection of areolar secretions)
Breast secretion samples
164 mothers
Measurement of VOCs during a film screening featuring various sensory characteristics of children + video and thermographic recording
57 awake newborns
Measurement of psychophysiological responses in sleeping newborns during exposure to maternal odors + video and thermographic recording
Measurement of sucking responses in awake newborns during exposure to maternal odors + video and thermographic recording
57 sleeping newborns
Measurement of psychophysiological responses in sleeping newborns during exposure to maternal odors + video and thermographic recording
Measurement of sucking responses in awake newborns during exposure to maternal odors + video and thermographic recording

この研究は何を測定していますか?

主要な結果の測定

結果測定
時間枠
Temporal variations in the occurrence of VOCs emitted in the odor of the lactating breast, measured in real time using proton transfer mass spectrometry
時間枠:Before, during, and after feeding, at day 0 during 3 hours
Before, during, and after feeding, at day 0 during 3 hours
Temporal variations in the relative concentration of VOCs emitted in the breath of nursing mothers, measured in real time using proton transfer mass spectrometry
時間枠:Before, during, and after feeding, at day 0 during few minutes
Before, during, and after feeding, at day 0 during few minutes
Maternal responsiveness (breast interoception, breast thermography measured by concurrent chemical analysis (PTR-ToF-MS) to identify systematic variations in the VOCs of breast odor) during visual, auditory, and olfactory presentation to the child video
時間枠:While breastfeeding at day 0 during 1 hour
While breastfeeding at day 0 during 1 hour
Behavioral responses in newborns exposed to samples of breast milk or to VOCs present in breast milk vapors, as measured by orofacial motor activity in sleeping newborns during active sleep phases
時間枠:While breastfeeding at day O during 30 to 45 minutes
While breastfeeding at day O during 30 to 45 minutes
Psychophysiological responses in newborns exposed to samples of breast milk or to VOCs present in breast milk vapors, as measured by heart and respiratory rates in sleeping newborns during active sleep phases
時間枠:While breastfeeding at day O during 30 to 45 minutes
While breastfeeding at day O during 30 to 45 minutes

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年5月1日

一次修了 (推定)

2032年5月1日

研究の完了 (推定)

2032年5月1日

試験登録日

最初に提出

2026年5月11日

QC基準を満たした最初の提出物

2026年5月26日

最初の投稿 (実際)

2026年5月29日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月29日

QC基準を満たした最後の更新が送信されました

2026年5月26日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • SIMON Stirling 2025

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する